Sumitomo Dainippon Pharma Co., Ltd.

Eiji Sugaru

Chiang Jia Li

Hitoshi Ban

Hiroki Yamaguchi

Shingo Tojo

Manabu Kusagi

Nobuyuki Sawada

Tsuguteru Otsubo

The present invention pertains to an imidazolylamide derivative represented by formula (1) that exhibits an exceptional suppressive effect on cancer cell sphere formation ability and that is useful as an antitumor agent that can be administered orally, or a pharmacologically acceptable salt thereof. [In the formula, ring Qrepresents a Caryl group or the like; m represents 0, 1, 2, 3, 4, or 5; R, independently when multiple, represent(s) a halogen atom or the like; Rand Rindependently represent a hydrogen atom or the like; Wrepresents a Calkylene group (said group may be substituted by 1-3 fluorine atoms or Ccycloalkyls); Wrepresents &#x2014;NRC(O)&#x2014; or the like (where Rrepresents a hydrogen atom or Calkyl group); and ring Qrepresents a Carylgroup or the like] 

Imidazolylamide derivative

Growing community of inventors

Osaka, Japan

Eiji Sugaru